Systematic review of systemic therapy for advanced or recurrent endometrial cancer.
about
Hormone replacement therapy for women previously treated for endometrial cancerHormonal therapy in advanced or recurrent endometrial cancerHormone therapy for advanced or recurrent endometrial cancerAvoidable mortality across Canada from 1975 to 1999Adjuvant hormonal therapy for stage I endometrial cancer.Endometrial cancer: what is new in adjuvant and molecularly targeted therapy?Rapamycin potentiates the effects of paclitaxel in endometrial cancer cells through inhibition of cell proliferation and induction of apoptosis.The anti-tumor activator sMEK1 and paclitaxel additively decrease expression of HIF-1α and VEGF via mTORC1-S6K/4E-BP-dependent signaling pathwaysEfficacy and safety of AEZS-108 (LHRH agonist linked to doxorubicin) in women with advanced or recurrent endometrial cancer expressing LHRH receptors: a multicenter phase 2 trial (AGO-GYN5).Long-term survival of endometrioid endometrial cancer patientsThe use of steroid sulfatase inhibitors as a novel therapeutic strategy against hormone-dependent endometrial cancer.Invasive endometrial lesion in a patient with mental retardation.Current treatment strategies for endometrial cancer.Pharmacotherapy of endometrial cancer.Taxanes: their impact on gynecologic malignancy.Role of epigenomics in ovarian and endometrial cancers.Anthracycline-based chemotherapy in metastatic endometrial carcinoma: an update.DNA methylation markers for early detection of women's cancer: promise and challenges.A molecular carrier to transport and deliver cisplatin into endometrial cancer cells.Probenecid is a chemosensitizer in cancer cell lines.Down-regulation of IGF-1R expression inhibits growth and enhances chemosensitivity of endometrial carcinoma in vitro.A multicentre phase II study of carboplatin plus pegylated liposomal doxorubicin as first-line chemotherapy for patients with advanced or recurrent endometrial carcinoma: the END-1 study of the MITO (Multicentre Italian Trials in Ovarian Cancer and G
P2860
Q24234201-9484CEDB-9DE8-4B8B-AC63-65E78B3609F5Q24235543-AC17B9C1-4FBD-4292-8583-0544E736C2D8Q24240723-EEEDB62F-CA24-41FE-AB3E-A4F09CA05727Q33244267-898F0F70-D9C3-431B-9F69-5ED05B46313CQ33348535-6F7A83C6-F07A-41BC-B576-5B43D78B4FBAQ33633962-EAF75AC8-C841-4945-B316-2544F9E93443Q33638550-C4D5D1F0-62FC-4600-AA9C-70CBCC52FFE6Q34227805-EC56BCCD-0403-4234-B79B-442A1F70F587Q34397557-F41C0B7A-810D-42BE-9743-9D9ABAD5FC0AQ35827414-DB16E22F-CA9F-4763-BCBD-C7B728C7666CQ36796680-8780D714-7591-422A-9DEB-A1216FB8579AQ36935555-2173D3DE-DD07-4D28-B1BB-A9DE6ED80E42Q37202781-277BA535-9043-44B7-9743-770415F5449DQ37544822-FCAB26E2-149E-43C1-B099-B17357DA3F2CQ37692801-30DFDC34-F508-4FC0-86CF-80FAE733EAB5Q37961734-58ACA87A-B709-46EB-BB2A-1E385D0042A4Q38061964-7286619E-6289-4FA8-AE5D-A98809FC75FDQ38238828-8DD988C5-3487-4C7B-B8C2-3BE1C396028FQ39409872-9755B552-87B5-470E-BB0E-F14B648D6A94Q39485986-CC2AB72A-13E7-45A9-B508-FFFA1DF4A8DAQ39569647-5229DAE6-0D84-41DB-85C5-E3F855059101Q57903847-727EBF79-BD50-4475-9FCC-B9E2C046B328
P2860
Systematic review of systemic therapy for advanced or recurrent endometrial cancer.
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Systematic review of systemic therapy for advanced or recurrent endometrial cancer.
@ast
Systematic review of systemic therapy for advanced or recurrent endometrial cancer.
@en
type
label
Systematic review of systemic therapy for advanced or recurrent endometrial cancer.
@ast
Systematic review of systemic therapy for advanced or recurrent endometrial cancer.
@en
prefLabel
Systematic review of systemic therapy for advanced or recurrent endometrial cancer.
@ast
Systematic review of systemic therapy for advanced or recurrent endometrial cancer.
@en
P2093
P1433
P1476
Systematic review of systemic therapy for advanced or recurrent endometrial cancer.
@en
P2093
Alexandra Chambers
Cancer Care Ontario Practice Guidelines Initiative Gynecology Cancer Disease Site Group
Christine Gawlik
Mark S Carey
Michael Fung-Kee-Fung
Tom Oliver
P304
P356
10.1016/J.YGYNO.2005.11.019
P407
P577
2006-01-24T00:00:00Z